Table 3.
Gene | RefSeq | Nucleotide | Protein | In Silico Pathogenicity Analysis | |||
---|---|---|---|---|---|---|---|
MutationTaster † | PolyPhen-2 ‡ | SIFT * | Cadd13 # | ||||
CEP290 | NM_025114 | c.1664A > T | p.(Lys555Ile) | LP | LP | P | 27.8 |
CEP290 | NM_025114 | c.1092T > G | p.(Ile364Met) | LP | P | P | 25.3 |
PRPF31 | NM_015629 | c.3G > A | p.(Met1Ile) | LP | B | P | 23.8 |
RHO | NM_000539 | c.560G > T | p.(Cys187Phe) | LP | P | P | 24.8 |
USH2A | NM_206933 | c.497A > G | p.(Glu166Gly) | LP | P | P | 26.2 |
USH2A | NM_206933 | c.3045C > G | p.(His1015Gln) | LP | LP | P | 22.8 |
USH2A | NM_206933 | c.6992G > A | p.(Gly2331Glu) | P | LP | P | 28.9 |
† http://www.mutationtaster.org/, ‡ Polymorphism Phenotyping v2; http://genetics.bwh.harvard.edu/pph2/, * Sorting Intolerant from Tolerant; http://sift.bii.a-star.edu.sg/, # Combined Annotation-Dependent Depletion; http://cadd.gs.washington.edu/, Abbreviations: B, benign; LP, likely pathogenic; P, pathogenic.